| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive Chairman
1 company
Kemble George is an Executive Chairman at Sagimet Biosciences Inc.. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $541K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2025 | SGMT Sagimet Biosciences Inc. | Executive Chairman | Sell | 37,688 | $7.69 | $289,979.01 | -31.8% | -27.8% | - | |
| Jul 23, 2024 | SGMT Sagimet Biosciences Inc. | Executive Chairman | Sell | 23,625 | $3.17 | $74,829.83 | -16.6% | +70.3% | +193.3% | |
| Jul 19, 2024 | SGMT Sagimet Biosciences Inc. | Executive Chairman | Sell | 14,062 | $3.10 | $43,604.86 | -9.0% | +74.8% | +204.5% |